Trial Results Search
Clinical Trial Results: Idiopathic Thrombocytopenic Purpura
Protocol Number: ML20948
Product Name: rituximab [MabThera/Rituxan] [rituximab]
Date of Report: 01.07.2012
A multi-centre, single-arm, open-label study to evaluate the efficacy and safety of 1000 mg fixed dose rituximab on days one and fifteen among patients with chronic or relapsing idiopathic thrombocytopenic purpura.
Protocol Number: ML18542
Product Name: rituximab [rituximab]
Date of Report: 01.09.2008
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.